Excellent
Mostly Aligned
Patient Risk:
Low
Summary
All four extracted claims were evaluated as absent_from_label due to lack of label content provided in the prompt. The evaluation appropriately reflects the absence of verifiable label sections for Cartia XT.
Category Scores
Accurate Statements
Unsupported Statements
Cartia XT es diltiazem.
Not supported by the supplied prescribing information (no label sections provided).
Cartia XT es una tableta de liberación prolongada (XT).
Not supported by the supplied prescribing information (no label sections provided).
Las dosis comunes de Cartia XT son 120 mg, 180 mg y 240 mg.
Not supported by the supplied prescribing information (no label sections provided).
Cartia XT puede tener versiones genéricas o equivalentes terapéuticos.
Not supported by the supplied prescribing information (no label sections provided).
Contradictions
Important Omissions
Active ingredient mapping (whether Cartia XT corresponds to diltiazem), formulation details (extended-release tablet), available strengths (e.g., 120 mg, 180 mg, 240 mg), and generic/therapeutic equivalence status.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
No patient-specific safety or risk information is provided in the evaluation.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
Yes |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Suggested Improvement
Obtain the official Cartia XT label and extract exact sections for active ingredient, dosage/form, strengths/strengths, indications, contraindications, boxed warnings, warnings/precautions, drug interactions, use in pregnancy and lactation, pediatrics, and dosage adjustments.